Literature DB >> 27707566

Simultaneous control of glycemic, blood pressure, and lipid significantly reduce the risk of renal progression in diabetes patients.

Po-Ya Chang1, Li-Nien Chien2, Yuh-Feng Lin3, Wen-Ta Chiu4, Hung-Yi Chiou5.   

Abstract

BACKGROUND AND AIM: Hyperglycemic, hypertension, and lipid abnormalities are risk factors for diabetic kidney disease However, no study has discussed the association of the simultaneous control of glycemic, blood pressure, and lipids with renal function among diabetes patients. Thus, this study examined the interactive effects of the intensive control of all 3 conditions on the progression of renal function.
MATERIALS AND METHODS: The study population was derived from eight hospitals in Taiwan from October 2008 to April 2015. Demographic characteristics were collected using structured questionnaires. Clinical variables were obtained from medical chart review. The renal progression was defined as a decline in the eGFR by more than 25% according to the baseline eGFR.
RESULTS: Total of 1602 diabetes patients were included in the study analysis, the mean age was 63.03±10.98years, 55.56% were men. Compared to the simultaneous control of glycemic, blood pressure and lipid group, the poor control of all three diseases had the highest risk of renal progression, with an adjusted OR of 2.21 (95% CI, 1.26-3.86). Even if the patients with an intensive control of lipid, the result showed that the poor control of both glycemic and hypertension was associated with the increased risk of renal progression than the reference group.
CONCLUSION: This study demonstrated that the simultaneous poor control of glycemic, blood pressure, and lipid had the highest risk of renal progression. Thus, patients with type 2 diabetes should not only control glycemic but also manage their blood pressure and lipid.
Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; Hypertension; Lipid; Managed care; Renal disease

Mesh:

Substances:

Year:  2016        PMID: 27707566     DOI: 10.1016/j.ejim.2016.09.013

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  2 in total

1.  Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention.

Authors:  Allison A Lewinski; Uptal D Patel; Clarissa J Diamantidis; Megan Oakes; Khaula Baloch; Matthew J Crowley; Jonathan Wilson; Jane Pendergast; Holly Biola; L Ebony Boulware; Hayden B Bosworth
Journal:  J Med Internet Res       Date:  2019-04-09       Impact factor: 5.428

2.  Continuity of care with physicians and risk of subsequent hospitalization and end-stage renal disease in newly diagnosed type 2 diabetes mellitus patients.

Authors:  Po-Ya Chang; Li-Nien Chien; Chyi-Huey Bai; Yuh-Feng Lin; Hung-Yi Chiou
Journal:  Ther Clin Risk Manag       Date:  2018-03-13       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.